Chronic hepatitis B virus (HBV) infection affects about 296 million people worldwide and is
the leading aetiology of cirrhosis and liver cancer globally. Major medical complications also …

Adipose tissue is a highly dynamic endocrine tissue and constitutes a central node in the
interorgan crosstalk network through adipokines, which cause pleiotropic effects, including …

Chronic hepatitis B virus (HBV) infection can lead to substantial morbidity and mortality.
Although treatment is not considered curative, antiviral treatment, monitoring, and liver …

Background and Aims Although prevalence of chronic hepatitis B (CHB) in the USA includes
0.42 million (range, 0.28‐0.67) US‐born persons, foreign‐born (FB) persons contribute a …

Background & Aims Chronic hepatitis B (CHB) infection remains the most frequent etiology
of hepatocellular carcinoma globally as well as a major cause of cirrhosis. Despite …

Background & Aims The occurrence of HBV-associated liver complications is reduced by
antiviral therapy. However, prior studies using local institutional cohorts have suggested that …

Chronic Hepatitis B is a highly prevalent disease worldwide and is estimated to cause more
than 800000 annual deaths from complications such as cirrhosis and hepatocellular …

Background and Aims Real‐world data for treatment effectiveness and renal outcomes in
chronic hepatitis B (CHB) patients who were switched to the new and safer prodrug tenofovir …

Summary Background The 2016 World Health Assembly endorsed the elimination of
hepatitis B virus (HBV) infections by 2030. However, the HBV prevalence in Western …

Chronic liver disease presents a significant global health burden, characterized by several
etiologies, including metabolic dysfunction-associated steatotic liver disease (MASLD) …